Inspire Medical Systems Inc [INSP] stock is trading at $124.41, down -2.29%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The INSP shares have gain 49.41% over the last week, with a monthly amount glided 65.50%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Inspire Medical Systems Inc [NYSE: INSP] stock has seen the most recent analyst activity on November 26, 2025, when Truist upgraded its rating to a Buy but kept the price target unchanged to $165 for it. Previously, Wolfe Research upgraded its rating to Outperform on November 25, 2025, and kept the price target unchanged to $180. On November 24, 2025, upgrade upgraded it’s rating to Buy. Wells Fargo upgraded its rating to an Overweight but stick to its price target of $90 on November 04, 2025. Jefferies downgraded its rating to a Hold but $85 remained the price target by the analyst firm on October 24, 2025. UBS downgraded its rating to Neutral for this stock on September 22, 2025, but kept the price target unchanged to $89. In a note dated September 02, 2025, Evercore ISI initiated an Outperform rating and provided a target price of $150 on this stock.
Inspire Medical Systems Inc [INSP] stock has fluctuated between $70.77 and $216.01 over the past year. Currently, Wall Street analysts expect the stock to reach $130.4 within the next 12 months. Inspire Medical Systems Inc [NYSE: INSP] shares were valued at $124.41 at the most recent close of the market. An investor can expect a potential return of 4.81% based on the average INSP price forecast.
Analyzing the INSP fundamentals
Inspire Medical Systems Inc [NYSE:INSP] reported sales of 882.62M for the trailing twelve months, which represents a growth of 10.49%. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.08 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 122.84 points at the first support level, and at 121.26 for the second support level. However, for the 1st resistance point, the stock is sitting at 126.90, and for the 2nd resistance point, it is at 129.39.
Ratios To Look Out For
For context, Inspire Medical Systems Inc’s Current Ratio is 5.29. Further, the Quick Ratio stands at 4.01, while the Cash Ratio is 1.15. Considering the valuation of this stock, the price to sales ratio is 4.10, the price to book ratio is 5.42 and price to earnings (TTM) ratio is 85.33.
Transactions by insiders
Recent insider trading involved SHAWN T MCCORMICK, Director, that happened on Nov 28 ’25 when 2000.0 shares were purchased. Director, Curet Myriam completed a deal on Mar 20 ’25 to buy 4.0 shares. Meanwhile, Director Curet Myriam bought 1.0 shares on Apr 07 ’25.
